You are assuming that the advertising is just a wasted expense. Obviously the companys are not just throwing money away. They have concluded that the advertising generates enough in additional sales to pay for the ads plus additional profit.
None of which necessarily motivates drug companies to develop new drugs.
Why bother spending R&D on things like diabetes prevention when you can market a nifty looking injector?
Why research heart drugs when you can market low dose aspirin under a trendy lifestyle brand?
Why address chronic pain when you can market the same ibuprofen as being suitable for several different types of condition, each at different price points?
Companies prefer to make money without investment or risk. Perfectly rational, but counter productive.
How much is spent in the USA on marketed drugs that have no greater effect than generics?
























